March 3, 2026Open Access

Tacrolimus-induced reversible posterior leukoencephalopathy syndrome in a child with nephrotic syndrome: a case report

Key Points

Tacrolimus can cause posterior leukoencephalopathy syndrome early in treatment, requiring prompt attention.
In this case, neurological symptoms were observed before stable drug concentrations were achieved.
Vigilant clinical monitoring is essential for early detection of symptoms related to neurological complications.
Timely intervention is critical to prevent potential long-term effects from tacrolimus-induced PRES.

Abstract

Tacrolimus-associated PRES may occur very early in treatment, even before stable drug concentrations are achieved. Vigilant clinical monitoring, prompt recognition of neurological symptoms, and timely intervention are critical to avoid long-term sequelae.

Demander à l'IA

Bookmark

View Full Paper